ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
ALTA-1L: Brigatinib vs crizotinib for ALK advanced non small cell lung cancer p...
Prof Sanjay Popat - The Royal Marsden Hospital, London, UK
Breast cancer roundup from ESMO 2020
Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy
OncoAlert and ecancer weekly roundup for September 14-19, 2020
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
IMpassion130: Atezolizumab and nab-paclitaxel in triple-negative breast cancer
Prof Leisha Emens - University of Pittsburgh, Pittsburgh, USA
ATTRACTION-4: Nivolumab plus chemotherapy for gastric or gastroesophageal cancer
Prof Narikazu Boku - National Cancer Center Hospital, Tokyo, Japan
Lenvatinib plus pembrolizumab for advanced melanoma that progressed on a PD-1 or...
Dr Ana Arance - Hospital Clinic Barcelona, Barcelona, Spain
Osimertinib adjuvant therapy in patients with early stage EGFR mutated NSCLC aft...
Dr Masahito Tsuboi - National Cancer Center Hospital, Tokyo, Japan
Latest updates to the ESMO bone health guidelines
Prof Robert Coleman - University of Sheffield, Sheffield, UK
CheckMate 649: Nivolumab plus chemotherapy for gastric and oesophageal cancers
Prof Markus Möhler - Universitätsmedizin Mainz, Mainz, Germany
AMG 160: A PSMA-targeted, bispecific T-cell engager immune therapy for mCRPC
Dr Ben Tran - Peter MacCallum Cancer Centre, Melbourne, Australia
Estimate of the 2-year oncology workload generated by each new patient: A real-w...
Dr Silvio Ken Garattini - University of Udine, Udine, Italy
Amivantamab lazertinib and other novel combinations in EGFR positive advanced NS...
Dr Alex Spira and Dr Joshua Sabari